Archive > Volume 29 Issue 2 > 2022,29(2):135-141. DOI:10.3872/j.issn.1007-385X.2022.02.008 Prev Next

Review

Advance of tumor neoantigen in triple-negative breast cancer

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.